{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:43:55Z","timestamp":1793033035162,"version":"4.5.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Super-enhancers are a super-cluster of enhancers formed by serially arranged regulatory elements that can strongly drive the expression of cell-related genes. Hundreds of SEs in cells affect cell identity and fate-determining processes. Previous studies have verified that the expression of pathogenic genes is highly correlated with the abnormal activation of SEs in malignant tumorigenesis, dementia, diabetes, and many autoimmune diseases. Also, enhancer RNAs (eRNAs) can be regarded as crucial markers for SEs. Here, we summarize the discovery process and basic concepts of SEs, describe the structural characteristics and functional regulation of SEs in different tumor diseases, Alzheimer\u2019s disease, and immune-related diseases, with a focus on typical diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. In this review, we also discuss the potential clinical applications of SE, as well as the research prospects in this field.<\/jats:p>","DOI":"10.3389\/fgene.2025.1611905","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:15:07Z","timestamp":1751429707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Current progress and future perspective of super-enhancers: a viable and effective bridge between the transcriptional apparatus and disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Ran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongran","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrg3293","article-title":"Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans","volume":"13","author":"Adelman","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"653669","DOI":"10.3389\/fcell.2021.653669","article-title":"Super-enhancers and CTCF in early embryonic cell fate decisions","volume":"9","author":"Agrawal","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/pgpm.S274246","article-title":"Influence of PSRC1, CELSR2, and SORT1 gene polymorphisms on the variability of warfarin dosage and susceptibility to cardiovascular disease","volume":"13","author":"Al-Eitan","year":"2020","journal-title":"Pharmgenomics Pers. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1038\/s41598-017-06516-1","article-title":"Novel risk genes for systemic lupus erythematosus predicted by random forest classification","volume":"7","author":"Alml\u00f6f","year":"2017","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/S2352-3026(16)00021-1","article-title":"Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study","volume":"3","author":"Amorim","year":"2016","journal-title":"Lancet Haematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/bies.201400162","article-title":"Promoter or enhancer, what's the difference? Deconstruction of established distinctions and presentation of a unifying model","volume":"37","author":"Andersson","year":"2015","journal-title":"BioEssays news Rev. Mol. Cell. Dev. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature12787","article-title":"An atlas of active enhancers across human cell types and tissues","volume":"507","author":"Andersson","year":"2014","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12859-020-03729-6","article-title":"Theoretical characterisation of strand cross-correlation in ChIP-seq","volume":"21","author":"Anzawa","year":"2020","journal-title":"BMC Bioinforma."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-16-2622","article-title":"Targeted degradation of BET proteins in triple-negative breast cancer","volume":"77","author":"Bai","year":"2017","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1101\/gad.1968210","article-title":"CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1","volume":"24","author":"Bartkowiak","year":"2010","journal-title":"Genes and Dev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1016\/j.cell.2023.11.030","article-title":"Super-enhancers include classical enhancers and facilitators to fully activate gene expression","volume":"186","author":"Blayney","year":"2023","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e12112","DOI":"10.15252\/emmm.202012112","article-title":"Resolving mechanisms of immune-mediated disease in primary CD4 T cells","volume":"12","author":"Bourges","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00439-016-1654-x","article-title":"Allele-specific transcription factor binding to common and rare variants associated with disease and gene expression","volume":"135","author":"Cavalli","year":"2016","journal-title":"Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates alzheimer genetic risk by modulating tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.7555\/jbr.37.20230206","article-title":"p53 exerts anticancer effects by regulating enhancer formation and activity","volume":"38","author":"Chen","year":"2024","journal-title":"J. Biomed. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","article-title":"CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-Driven cancer","volume":"159","author":"Chipumuro","year":"2014","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.3390\/ijms23084174","article-title":"GZ17-6.02 inhibits the growth of EGFRvIII+ glioblastoma","volume":"23","author":"Choi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2019.04.190","article-title":"The SNP of rs6854845 suppresses transcription via the DNA looping structure alteration of super-enhancer in Colon cells","volume":"514","author":"Cong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ng.249","article-title":"Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci","volume":"40","author":"Cooper","year":"2008","journal-title":"Nat. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1000384","DOI":"10.1371\/journal.pbio.1000384","article-title":"A large fraction of extragenic RNA pol II transcription sites overlap enhancers","volume":"8","author":"De Santa","year":"2010","journal-title":"PLoS Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/molecules23051003","article-title":"Targeting GLI transcription factors in cancer","volume":"23","author":"Didiasova","year":"2018","journal-title":"Mol. Basel, Switz."},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.ircmb.2023.03.013","article-title":"Super-enhancer landscape rewiring in cancer: the epigenetic control at distal sites","volume":"380","author":"Di Giorgio","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.celrep.2014.08.055","article-title":"Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes","volume":"9","author":"Di Micco","year":"2014","journal-title":"Cell Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cell.2014.09.030","article-title":"Control of cell identity genes occurs in insulated neighborhoods in Mammalian chromosomes","volume":"159","author":"Dowen","year":"2014","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1800242024","DOI":"10.1523\/jneurosci.1800-24.2024","article-title":"Transcription factor-wide association studies to identify functional SNPs in alzheimer's disease","volume":"45","author":"Dunn","year":"2025","journal-title":"J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101729","DOI":"10.1016\/j.tranon.2023.101729","article-title":"Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins","volume":"35","author":"Dutta","year":"2023","journal-title":"Transl. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/s0140-6736(11)60874-x","article-title":"Identification of IL6R and chromosome 11q13.5 as risk loci for asthma","volume":"378","author":"Ferreira","year":"2011","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molcel.2015.09.001","article-title":"YAP drives growth by controlling transcriptional pause release from dynamic enhancers","volume":"60","author":"Galli","year":"2015","journal-title":"Mol. cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.crvi.2016.05.009","article-title":"From mendel to epigenetics: history of genetics","volume":"339","author":"Gayon","year":"2016","journal-title":"C R. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11248-021-00247-w","article-title":"A short overview of CRISPR-cas technology and its application in viral disease control","volume":"30","author":"Ghorbani","year":"2021","journal-title":"Transgenic Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.18632\/oncotarget.26704","article-title":"Super-enhancers: novel target for pancreatic ductal adenocarcinoma","volume":"10","author":"Ghosh","year":"2019","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10577-018-9571-6","article-title":"Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells","volume":"26","author":"Glinsky","year":"2018","journal-title":"Chromosome Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","article-title":"A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia","volume":"157","author":"Gr\u00f6schel","year":"2014","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2147\/jir.S331188","article-title":"Transcriptional landscape of enhancer RNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"15","author":"Guo","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"E297","DOI":"10.1073\/pnas.1424028112","article-title":"Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs","volume":"112","author":"Hah","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.cell.2011.03.042","article-title":"A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells","volume":"145","author":"Hah","year":"2011","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","article-title":"Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers","volume":"58","author":"Hnisz","year":"2015","journal-title":"Mol. cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1361","DOI":"10.1002\/ctm2.1361","article-title":"METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma","volume":"13","author":"Hu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/s41467-021-22445-0","article-title":"Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"103825","DOI":"10.1016\/j.ebiom.2022.103825","article-title":"Reduced chromatin accessibility to CD4 T cell super-enhancers encompassing susceptibility loci of rheumatoid arthritis","volume":"76","author":"Jadhav","year":"2022","journal-title":"EBioMedicine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-020-0428-7","article-title":"Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms","volume":"52","author":"Jia","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ydbio.2009.08.009","article-title":"Regulation of gene expression via the core promoter and the basal transcriptional machinery","volume":"339","author":"Juven-Gershon","year":"2010","journal-title":"Dev. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature09380","article-title":"Mediator and cohesin connect gene expression and chromatin architecture","volume":"467","author":"Kagey","year":"2010","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2013.07.010","article-title":"Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription","volume":"51","author":"Kaikkonen","year":"2013","journal-title":"Mol. cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"30178","DOI":"10.18632\/oncotarget.4903","article-title":"Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1\/CDK4 pathway inhibition in ewing sarcoma","volume":"6","author":"Kennedy","year":"2015","journal-title":"Oncotarget"},{"key":"B55","doi-asserted-by":"publisher","first-page":"D164","DOI":"10.1093\/nar\/gkv1002","article-title":"dbSUPER: a database of super-enhancers in mouse and human genome","volume":"44","author":"Khan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature09033","article-title":"Widespread transcription at neuronal activity-regulated enhancers","volume":"465","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2015.08.008","article-title":"Architectural and functional commonalities between enhancers and promoters","volume":"162","author":"Kim","year":"2015","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.celrep.2016.08.083","article-title":"Reversible regulation of promoter and enhancer histone landscape by DNA methylation in mouse embryonic stem cells","volume":"17","author":"King","year":"2016","journal-title":"Cell Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000135626","article-title":"Immune-endocrine interactions in autoimmune thyroid diseases","volume":"15","author":"Klecha","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nsmb.2085","article-title":"Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters","volume":"18","author":"Koch","year":"2011","journal-title":"Nat. Struct. and Mol. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41467-019-09710-z","article-title":"Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm","volume":"10","author":"Kubota","year":"2019","journal-title":"Nat. Commun."},{"key":"B63","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.tibs.2014.02.007","article-title":"Enhancer RNAs and regulated transcriptional programs","volume":"39","author":"Lam","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cell.2014.02.009","article-title":"Looping back to leap forward: transcription enters a new era","volume":"157","author":"Levine","year":"2014","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tips.2019.11.006","article-title":"Strategies for the CRISPR-based therapeutics","volume":"41","author":"Li","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41588-023-01568-8","article-title":"Super-enhancer RNA m(6)A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma","volume":"55","author":"Li","year":"2023","journal-title":"Nat. Genet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1128\/MCB.01426-14","article-title":"Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing","volume":"35","author":"Liang","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2006.06.035","article-title":"Interchromosomal interactions and olfactory receptor choice","volume":"126","author":"Lomvardas","year":"2006","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2019.00488","article-title":"The association between vitamin D and multiple sclerosis risk: 1,25(OH)(2)D(3) induces super-enhancers bound by VDR","volume":"10","author":"Lu","year":"2019","journal-title":"Front. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature25169","article-title":"Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling","volume":"553","author":"Mack","year":"2018","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Sci. (New York, NY)"},{"key":"B75","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/90935","article-title":"Autoimmune disease: why and where it occurs","volume":"7","author":"Marrack","year":"2001","journal-title":"Nat. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.3324\/haematol.2018.192807","article-title":"Antitumor synergy with SY-1425, a selective RAR\u03b1 agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia","volume":"104","author":"McKeown","year":"2019","journal-title":"Haematologica"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1146\/annurev.bi.54.070185.005333","article-title":"Eukaryotic protein synthesis","volume":"54","author":"Moldave","year":"1985","journal-title":"Annu. Rev. Biochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.tibtech.2019.01.009","article-title":"Improving CRISPR genome editing by engineering guide RNAs","volume":"37","author":"Moon","year":"2019","journal-title":"Trends Biotechnol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.celrep.2015.06.078","article-title":"Deregulation of the ras-erk signaling axis modulates the enhancer landscape","volume":"12","author":"Nabet","year":"2015","journal-title":"Cell Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-021-03446-x","article-title":"Genome-wide enhancer maps link risk variants to disease genes","volume":"593","author":"Nasser","year":"2021","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.1236083","article-title":"Organization of the mitotic chromosome","volume":"342","author":"Naumova","year":"2013","journal-title":"Sci. (New York, NY)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/03009740510018633","article-title":"Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register","volume":"34","author":"Odeg\u00e5rd","year":"2005","journal-title":"Scand. J. Rheumatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrg2957","article-title":"Enhancer function: new insights into the regulation of tissue-specific gene expression","volume":"12","author":"Ong","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.celrep.2015.08.046","article-title":"Inhibition of super-enhancer activity in autoinflammatory site-derived T cells reduces disease-associated gene expression","volume":"12","author":"Peeters","year":"2015","journal-title":"Cell Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature14904","article-title":"Mediator kinase inhibition further activates super-enhancer-associated genes in AML","volume":"526","author":"Pelish","year":"2015","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2014.06.015","article-title":"Enhancer function: mechanistic and genome-wide insights come together","volume":"55","author":"Plank","year":"2014","journal-title":"Mol. cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","article-title":"What are super-enhancers?","volume":"47","author":"Pott","year":"2015","journal-title":"Nat. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat. Genet."},{"key":"B92","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41420-023-01775-6","article-title":"Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets","volume":"9","author":"Qian","year":"2023","journal-title":"Cell Death Discov."},{"key":"B93","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrd3669","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B94","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-enhancer-driven transcriptional dependencies in cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cell.2015.02.040","article-title":"The role of chromosome domains in shaping the functional genome","volume":"160","author":"Sexton","year":"2015","journal-title":"Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.molimm.2018.09.019","article-title":"Enhancer RNA and NF\u03baB-dependent P300 regulation of ADAMDEC1","volume":"103","author":"Shi","year":"2018","journal-title":"Mol. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14348\/molcells.2018.2297","article-title":"Targeting super-enhancers for disease treatment and diagnosis","volume":"41","author":"Shin","year":"2018","journal-title":"Mol. cells"},{"key":"B99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41540-025-00533-x","article-title":"SEgene identifies links between super enhancers and gene expression across cell types","volume":"11","author":"Shinkai","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"key":"B100","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11696","article-title":"Insights into bilaterian evolution from three Spiralian genomes","volume":"493","author":"Simakov","year":"2013","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acr.23789","article-title":"Special article: 2018 American college of rheumatology\/national psoriasis foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Care Res. Hob."},{"key":"B102","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2796.2012.02563.x","article-title":"Genetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysis","volume":"272","author":"Smith","year":"2012","journal-title":"J. Intern Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature03574","article-title":"Interchromosomal associations between alternatively expressed loci","volume":"435","author":"Spilianakis","year":"2005","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrc.2016.62","article-title":"The role of enhancers in cancer","volume":"16","author":"Sur","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/rheumatology\/key280","article-title":"The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?","volume":"58","author":"Tanaka","year":"2019","journal-title":"Rheumatol. Oxf."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/cancers14122866","article-title":"Super-enhancers, phase-separated condensates, and 3D genome organization in cancer","volume":"14","author":"Tang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2159-8290.CD-16-0217","article-title":"BRD4 connects enhancer remodeling to senescence immune surveillance","volume":"6","author":"Tasdemir","year":"2016","journal-title":"Cancer Discov."},{"key":"B109","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaut.2016.08.001","article-title":"The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned","volume":"74","author":"Teruel","year":"2016","journal-title":"J. Autoimmun."},{"key":"B110","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41467-018-06356-1","article-title":"Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation","volume":"9","author":"Teumer","year":"2018","journal-title":"Nat. Commun."},{"key":"B111","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/1078-0432.CCR-13-3346","article-title":"Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma","volume":"21","author":"Trabucco","year":"2015","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2020-218189","article-title":"Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis","volume":"80","author":"Tsuchiya","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12864-021-08092-1","article-title":"Identification of cell states using super-enhancer RNA","volume":"22","author":"Tu","year":"2021","journal-title":"BMC Genomics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1101\/gr.196006.115","article-title":"Active chromatin and transcription play a key role in chromosome partitioning into topologically associating domains","volume":"26","author":"Ulianov","year":"2016","journal-title":"Genome Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature14154","article-title":"Super-enhancers delineate disease-associated regulatory nodes in T cells","volume":"520","author":"Vahedi","year":"2015","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrrheum.2012.237","article-title":"Genetics and epigenetics of rheumatoid arthritis","volume":"9","author":"Viatte","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nature10006","article-title":"Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA","volume":"474","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1073\/pnas.1315023111","article-title":"NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B119","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13046-023-02763-5","article-title":"Super-enhancers complexes zoom in transcription in cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"D172","DOI":"10.1093\/nar\/gkv1243","article-title":"SEA: a super-enhancer archive","volume":"44","author":"Wei","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"B122","doi-asserted-by":"publisher","first-page":"e23422","DOI":"10.1002\/dvg.23422","article-title":"The mechanism and function of super enhancer RNA","volume":"59","author":"Xiao","year":"2021","journal-title":"Genesis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41467-024-45585-5","article-title":"Oncoprotein SET-Associated transcription factor ZBTB11 triggers lung cancer metastasis","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"B124","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-020-00124-9","article-title":"Critical roles of super-enhancers in the pathogenesis of autoimmune diseases","author":"Yamagata","year":"2020","journal-title":"Inflamm. Regen."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e2207201119","DOI":"10.1073\/pnas.2207201119","article-title":"Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B126","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/BOR.0b013e3280126b66","article-title":"Work disability in rheumatic diseases","volume":"19","author":"Yelin","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jhep.2015.07.008","article-title":"Emerging evidence on the role of the Hippo\/YAP pathway in liver physiology and cancer","volume":"63","author":"Yimlamai","year":"2015","journal-title":"J. hepatology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/s41388-019-1013-1","article-title":"Oncogenic HOXB8 is driven by MYC-Regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1","volume":"39","author":"Ying","year":"2020","journal-title":"Oncogene"},{"key":"B129","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2019.08.016","article-title":"Mediator condensates localize signaling factors to key cell identity genes","volume":"76","author":"Zamudio","year":"2019","journal-title":"Mol. Cell"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1158\/1078-0432.CCR-19-1418","article-title":"Targeting super-enhancer-associated oncogenes in osteosarcoma with THZ2, a covalent CDK7 inhibitor","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e2204716119","DOI":"10.1073\/pnas.2204716119","article-title":"Super-enhancers conserved within placental mammals maintain stem cell pluripotency","volume":"119","author":"Zhang","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B132","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nchembio.2166","article-title":"Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e72837","DOI":"10.7554\/eLife.72837","article-title":"STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus","volume":"11","author":"Zhang","year":"","journal-title":"Elife"},{"key":"B134","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3892\/ol.2020.11855","article-title":"Targeting complexes of super-enhancers is a promising strategy for cancer therapy","volume":"20","author":"Zheng","year":"2020","journal-title":"Oncol. Lett."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1611905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:15:08Z","timestamp":1751429708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1611905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":135,"alternative-id":["10.3389\/fgene.2025.1611905"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1611905","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1611905"}}